Palpebral xanthelasma and cardiometabolic risk: a systematized review
DOI:
https://doi.org/10.35381/s.v.v10i2.5257Keywords:
Xanthomatosis, eyelids, dyslipidemias, cardiovascular diseases, atherosclerosis, (Source: DeCS).Abstract
Palpebral xanthelasma is the most common form of cutaneous xanthoma, and its value as a marker of cardiometabolic risk remains under discussion. Objective: To analyze the evidence on the relationship between palpebral xanthelasma, lipid abnormalities, and cardiovascular risk. Method: Systematized review in PubMed/MEDLINE and SciELO with predefined eligibility criteria; 9 studies were selected. Results: A meta-analysis of 15 case-control studies showed higher total cholesterol, LDL cholesterol, and apolipoprotein B, and greater carotid intima-media thickness. In a cohort of 12,745 people, xanthelasma predicted myocardial infarction (HR 1.48) independently of lipids; however, the meta-analysis of events was inconclusive and some studies found no differences. Conclusion: Xanthelasma warrants lipid and global cardiovascular risk assessment, although it is not, by itself, an established predictor of events.
Downloads
References
Nair PA, Singhal R. Xanthelasma palpebrarum - a brief review. Clin Cosmet Investig Dermatol. 2018;11:1-5. https://doi.org/10.2147/CCID.S130116
Dornelas MT, Pedrosa NV, Dornelas GV, Chaoubah A, Fernandes AS, Carvalho EL, et al. Xantelasma palpebral: tratamento cirúrgico como primeira escolha. Rev Bras Cir Plást. 2022;37(4):498-504. https://doi.org/10.5935/2177-1235.2022RBCP.601-pt
Christoffersen M, Frikke-Schmidt R, Schnohr P, Jensen GB, Nordestgaard BG, Tybjærg-Hansen A. Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. BMJ. 2011;343:d5497. https://doi.org/10.1136/bmj.d5497
Lousa R, Alves M, Mota C, Brito D, Almeida AG, Pinto FJ, et al. The association of xanthelasma palpebrum with cardiovascular events: systematic review with meta-analysis. Eur J Prev Cardiol. 2022;29(13):1740-3. https://doi.org/10.1093/eurjpc/zwac070
Chang HC, Sung CW, Lin MH. Serum lipids and risk of atherosclerosis in xanthelasma palpebrarum: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;82(3):596-605. https://pubmed.ncbi.nlm.nih.gov/31499151/
Özdöl S, Şahin S, Tokgözoğlu L. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a). Int J Dermatol. 2008;47(8):785-9. https://doi.org/10.1111/j.1365-4632.2008.03690.x
Akyuz AR, Agac MT, Turan T, Sahin S, Kul S, Korkmaz L, et al. Xanthelasma is associated with an increased amount of epicardial adipose tissue. Med Princ Pract. 2016;25(2):187-90. https://doi.org/10.1159/000441846
Noel B. Premature atherosclerosis in patients with xanthelasma. J Eur Acad Dermatol Venereol. 2007;21(9):1244-8. https://pubmed.ncbi.nlm.nih.gov/17894713/
Yavari N, et al. Xanthelasma and its association with developing major cardio-cerebrovascular events. Atherosclerosis. 2026:120647. https://doi.org/10.1016/j.atherosclerosis.2026.120647
Bineshfar N, Schmuter G, Shah J, Godfrey K, Lee WW. Eyelid xanthelasma and cardiovascular outcomes: a propensity-matched analysis. Ophthalmic Plast Reconstr Surg. 2026. https://doi.org/10.1097/IOP.0000000000003187
Lustig-Barzelay Y, Kapelushnik N, Goldshtein I, et al. Association between xanthelasma palpebrarum with cardiovascular risk and dyslipidemia: a case control study. Ophthalmology. 2024. https://doi.org/10.1016/j.ophtha.2024.07.033
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Michelle Valeria Zeballos-García, Allison Mishell Avellan-Aguirre, Andy Efrain Fernández-Luna, Anthony Andrés López-Solórzano

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.



